Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 50

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 50
---
 such, the board did not provide Mr. Stack with an increase in his base salary for 2024. (3) Ms. Riker served as interim Chief Financial Officer from October 1, 2024 to October 20, 2024. As such, her 2023 base salary was not previously reported. (4) Dr. Slonin was promoted to Chief Medical Officer in December 2023 and received an increase in connection with his promotion at that time. He did not receive a base salary increase in 2024 as a result. Annual Incentive Bonuses The People & Compensation Committee believes that annual incentive bonuses that are awarded to our named executive officers based on Company and individual performance goals provide our named executive officers additional incentive to outperform our financial goals, increase stockholder value and ensure that we attract and retain talented named executive officers. Each year, the People & Compensation Committee establishes a target annual incentive award for each named executive officer expressed as a percentage of the executive’s base salary, based on results of Aon’s comparative assessment regarding annual incentive award targets for comparable positions at peer companies, the estimated contribution and responsibility of the individual named executive officer and market practices. The Company’s performance goals include those that are both financial and non-financial in nature, while individual performance goals are assessed based on the executive’s performance vis a vis both the Company’s performance goals as well as individual and departmental goals. Company and Individual performance is capped at 150% achievement for each goal. No named executive officer achieved this maximum level of performance for any goal during 2024, which highlights the rigorousness of the Company’s performance goals.

Pacira BioSciences, Inc. 2025 Proxy Statement | 63

TABLE OF CONTENTS Executive Compensation

These annual incentive bonuses are short-term and variable in nature and are separate from amounts earned under the cash LTIP, as discussed below. 2024 ANNUAL INCENTIVE BONUS TARGETS AND PAYOUTS For 2024, the targets for our named executive officers and actual payouts were as follows:

| ​                           | ​ | ​ |   |   |    |   | 2024 Annual Incentive Bonus(as a Percentage of Base Salary)(1)(2) | ​ |
| Named Executive Officer     | ​ | ​ |   |   |    |   | Target                                                            | ​ |
| Frank Lee                   | ​ | ​ | ​ | ​ | 85 | % | ​                                                                 | ​ |
| David Stack(3)